First United Bank & Trust’s NeoGenomics NEO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $336K | Hold |
23,000
| – | – | 0.1% | 127 |
|
|
2026
Q1 | $171K | Hold |
23,000
| – | – | 0.06% | 150 |
|
|
2025
Q4 | $270K | Sell |
23,000
-3,000
| -12% | -$32.4K | 0.09% | 134 |
|
|
2025
Q3 | $201K | Hold |
26,000
| – | – | 0.07% | 153 |
|
|
2025
Q2 | $190K | Hold |
26,000
| – | – | 0.07% | 149 |
|
|
2025
Q1 | $247K | Hold |
26,000
| – | – | 0.09% | 132 |
|
|
2024
Q4 | $428K | Hold |
26,000
| – | – | 0.16% | 103 |
|
|
2024
Q3 | $384K | Hold |
26,000
| – | – | 0.14% | 113 |
|
|
2024
Q2 | $361K | Hold |
26,000
| – | – | 0.13% | 114 |
|
|
2024
Q1 | $409K | Hold |
26,000
| – | – | 0.15% | 111 |
|
|
2023
Q4 | $421K | Hold |
26,000
| – | – | 0.17% | 110 |
|
|
2023
Q3 | $320K | Hold |
26,000
| – | – | 0.15% | 115 |
|
|
2023
Q2 | $418K | Hold |
26,000
| – | – | 0.19% | 107 |
|
|
2023
Q1 | $452K | Hold |
26,000
| – | – | 0.21% | 102 |
|
|
2022
Q4 | $240K | Hold |
26,000
| – | – | 0.12% | 135 |
|
|
2022
Q3 | $224K | Hold |
26,000
| – | – | 0.11% | 133 |
|
|
2022
Q2 | $212K | Hold |
26,000
| – | – | 0.1% | 141 |
|
|
2022
Q1 | $316K | Hold |
26,000
| – | – | 0.12% | 129 |
|
|
2021
Q4 | $887K | Hold |
26,000
| – | – | 0.33% | 85 |
|
|
2021
Q3 | $1.25M | Hold |
26,000
| – | – | 0.51% | 61 |
|
|
2021
Q2 | $1.17M | Hold |
26,000
| – | – | 0.49% | 60 |
|
|
2021
Q1 | $1.25M | Sell |
26,000
-1,000
| -4% | -$52.1K | 0.54% | 59 |
|
|
2020
Q4 | $1.45M | Hold |
27,000
| – | – | 0.7% | 49 |
|
|
2020
Q3 | $996K | Sell |
27,000
-3,000
| -10% | -$112K | 0.56% | 63 |
|
|
2020
Q2 | $929K | Hold |
30,000
| – | – | 0.55% | 63 |
|
|
2020
Q1 | $828K | Hold |
30,000
| – | – | 0.59% | 57 |
|
|
2019
Q4 | $878K | Hold |
30,000
| – | – | 0.51% | 65 |
|
|
2019
Q3 | $573K | Hold |
30,000
| – | – | 0.36% | 82 |
|
|
2019
Q2 | $658K | Sell |
30,000
-4,000
| -12% | -$87.8K | 0.39% | 76 |
|
|
2019
Q1 | $695K | Hold |
34,000
| – | – | 0.43% | 74 |
|
|
2018
Q4 | $429K | Hold |
34,000
| – | – | 0.3% | 81 |
|
|
2018
Q3 | $522K | Hold |
34,000
| – | – | 0.33% | 82 |
|
|
2018
Q2 | $446K | Sell |
34,000
-5,000
| -13% | -$55K | 0.3% | 83 |
|
|
2018
Q1 | $318K | Hold |
39,000
| – | – | 0.21% | 91 |
|
|
2017
Q4 | $346K | Hold |
39,000
| – | – | 0.23% | 90 |
|
|
2017
Q3 | $434K | Sell |
39,000
-5,000
| -11% | -$48.7K | 0.29% | 84 |
|
|
2017
Q2 | $394K | Hold |
44,000
| – | – | 0.27% | 88 |
|
|
2017
Q1 | $347K | Hold |
44,000
| – | – | 0.24% | 93 |
|
|
2016
Q4 | $377K | Hold |
44,000
| – | – | 0.28% | 89 |
|
|
2016
Q3 | $362K | Hold |
44,000
| – | – | 0.3% | 76 |
|
|
2016
Q2 | $354K | Sell |
44,000
-11,000
| -20% | -$88.2K | 0.31% | 76 |
|
|
2016
Q1 | $371K | Buy |
+55,000
| New | +$362K | 0.34% | 71 |
|
Other funds holding NEO
PCM
MWM
MNBTD
LSERS
SOADOR
PFSRSONJ
First United Bank & Trust's NEO Position: Q2 2026 in Review
First United Bank & Trust held its NeoGenomics (NEO) position steady in Q2 2026 at 23,000 shares worth $336K. The position accounts for 0.1% of the portfolio, ranked #127.
First United Bank & Trust first reported a position in NEO in Q1 2016 and has held it in 42 quarters since. The position peaked at $1.45M in Q4 2020. 57 funds tracked by Wall St. Rank hold NEO as of Q2 2026.
- First United Bank & Trust held 23,000 shares of NeoGenomics worth $336K as of Q2 2026.
- First United Bank & Trust left its NeoGenomics share count unchanged in Q2 2026.
- NeoGenomics made up 0.1% of First United Bank & Trust's portfolio in Q2 2026, its #127 holding.
- First United Bank & Trust first reported a position in NeoGenomics in Q1 2016 and has held it in 42 quarters since.
- First United Bank & Trust's NeoGenomics position peaked at $1.45M in Q4 2020.
- 57 funds tracked by Wall St. Rank held NeoGenomics as of Q2 2026.
Based on First United Bank & Trust's 13F filing for Q2 2026, filed 20 Jul 2026.